Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Victrex PLC Remuneration Information 2018

Dec 3, 2018

5290_rns_2018-12-03_10f89dba-941c-4a98-bbdf-0a9c1ba4f0ef.html

Remuneration Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2026J

Victrex PLC

03 December 2018

BLOCK LISTING SIX MONTHLY RETURN

Date: 3 December 2018

Name of applicant: Victrex plc
Period of return: From 1-6-2018 To: 30/11/2018
Name of scheme: 2005 Executive Share Option Plan, 2005 Share Save Plan, 2005 Stock Purchase Plan 2005 Executive Share Option Plan 2005 Share Save Plan 2005 Stock Purchase Plan 2015 Executive Share Option Plan 2015 UK Sharesave Plan 2015 Employee Stock Purchase Plan Total
Balance of unalloted securities under scheme(s) from previous return: 176,648 500,000 160,408 50,000 593,479 358,722 16,520 1,855,777
Plus: The amount by which the block scheme(s) has been increased since the date of the last return: - - - - - - - -
Less: Number of securities issued/ allotted under scheme(s) during period: 41,704 - 228 - 4,020 6,101 - 52,053
Equals: Balance under scheme(s) not yet issued/allotted at the end of the period: 134,944 500,000 160,180 50,000 589,459 352,621 16,520 1,803,724
Name of contact: Claire Lowry
Telephone number of contact: 01253 897747
LEI Number 213800UYNPHAUNHPXL67

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLREANADEAAPFEF